• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CRISPR-Cpf1 系统及其在动物基因组编辑中的应用。

CRISPR-Cpf1 system and its applications in animal genome editing.

机构信息

College of Tobacco Science and Engineering, Zhengzhou University of Light Industry, Zhengzhou, 450002, Henan, China.

Stem Cells and Biotherapy Engineering Research Center of Henan, National Joint Engineering Laboratory of Stem Cells and Biotherapy, School of Life Science and Technology, Xinxiang Medical University, Number 601, Jinsui Road, Xinxiang, 453003, Henan, China.

出版信息

Mol Genet Genomics. 2024 Aug 1;299(1):75. doi: 10.1007/s00438-024-02166-x.

DOI:10.1007/s00438-024-02166-x
PMID:39085660
Abstract

The clustered regularly interspaced short palindromic repeats (CRISPR) and their associated protein (Cas) system is a gene editing technology guided by RNA endonuclease. The CRISPR-Cas12a (also known as CRISPR-Cpf1) system is extensively utilized in genome editing research due to its accuracy and high efficiency. In this paper, we primarily focus on the application of CRISPR-Cpf1 technology in the construction of disease models and gene therapy. Firstly, the structure and mechanism of the CRISPR-Cas system are introduced. Secondly, the similarities and differences between CRISPR-Cpf1 and CRISPR-Cas9 technologies are compared. Thirdly, the main focus is on the application of the CRISPR-Cpf1 system in cell and animal genome editing. Finally, the challenges faced by CRISPR-Cpf1 technology and corresponding strategies are analyzed. Although CRISPR-Cpf1 technology has certain off-target effects, it can effectively and accurately edit cell and animal genomes, and has significant advantages in the preclinical research.

摘要

簇状规律间隔短回文重复序列(CRISPR)及其相关蛋白(Cas)系统是一种由 RNA 内切酶指导的基因编辑技术。CRISPR-Cas12a(也称为 CRISPR-Cpf1)系统由于其准确性和高效率,在基因组编辑研究中得到了广泛应用。本文主要关注 CRISPR-Cpf1 技术在疾病模型构建和基因治疗中的应用。首先,介绍了 CRISPR-Cas 系统的结构和机制。其次,比较了 CRISPR-Cpf1 和 CRISPR-Cas9 技术的异同。再次,重点介绍了 CRISPR-Cpf1 系统在细胞和动物基因组编辑中的应用。最后,分析了 CRISPR-Cpf1 技术面临的挑战及相应策略。虽然 CRISPR-Cpf1 技术存在一定的脱靶效应,但它可以有效地、精确地编辑细胞和动物基因组,在临床前研究中具有显著优势。

相似文献

1
CRISPR-Cpf1 system and its applications in animal genome editing.CRISPR-Cpf1 系统及其在动物基因组编辑中的应用。
Mol Genet Genomics. 2024 Aug 1;299(1):75. doi: 10.1007/s00438-024-02166-x.
2
Gene Manipulation Using Fusion Guide RNAs for Cas9 and Cas12a.使用融合向导 RNA 对 Cas9 和 Cas12a 进行基因操作。
Methods Mol Biol. 2021;2162:185-193. doi: 10.1007/978-1-0716-0687-2_10.
3
[The new generation tool for CRISPR genome editing: CRISPR/Cpf1].[用于CRISPR基因组编辑的新一代工具:CRISPR/Cpf1]
Sheng Wu Gong Cheng Xue Bao. 2017 Mar 25;33(3):361-371. doi: 10.13345/j.cjb.170029.
4
Design and assessment of engineered CRISPR-Cpf1 and its use for genome editing.设计和评估工程化的 CRISPR-Cpf1 及其在基因组编辑中的应用。
Nat Protoc. 2018 May;13(5):899-914. doi: 10.1038/nprot.2018.004. Epub 2018 Apr 5.
5
Cas9, Cpf1 and C2c1/2/3-What's next?Cas9、Cpf1 和 C2c1/2/3——接下来是什么?
Bioengineered. 2017 May 4;8(3):265-273. doi: 10.1080/21655979.2017.1282018. Epub 2017 Jan 31.
6
CRISPR/Cas System: Recent Advances and Future Prospects for Genome Editing.CRISPR/Cas 系统:基因组编辑的最新进展和未来前景。
Trends Plant Sci. 2019 Dec;24(12):1102-1125. doi: 10.1016/j.tplants.2019.09.006. Epub 2019 Nov 11.
7
Optimized CRISPR-Cpf1 system for genome editing in zebrafish.优化的 CRISPR-Cpf1 系统在斑马鱼中的基因组编辑。
Methods. 2018 Nov 1;150:11-18. doi: 10.1016/j.ymeth.2018.06.014. Epub 2018 Jun 28.
8
CRISPR-Cas12a System for Biosensing and Gene Regulation.用于生物传感和基因调控的CRISPR-Cas12a系统
Chem Asian J. 2021 Apr 19;16(8):857-867. doi: 10.1002/asia.202100043. Epub 2021 Mar 18.
9
A Survey of Genome Editing Activity for 16 Cas12a Orthologs.16 种 Cas12a 同源物的基因组编辑活性研究综述
Keio J Med. 2020 Sep 25;69(3):59-65. doi: 10.2302/kjm.2019-0009-OA. Epub 2019 Nov 14.
10
CRISPR-Cpf1 assisted genome editing of Corynebacterium glutamicum.CRISPR-Cpf1 辅助的谷氨酸棒杆菌基因组编辑。
Nat Commun. 2017 May 4;8:15179. doi: 10.1038/ncomms15179.

引用本文的文献

1
Research Progress and Application of Miniature CRISPR-Cas12 System in Gene Editing.微型CRISPR-Cas12系统在基因编辑中的研究进展与应用
Int J Mol Sci. 2024 Nov 26;25(23):12686. doi: 10.3390/ijms252312686.

本文引用的文献

1
Modulating the PI3K Signalling Pathway in Activated PI3K Delta Syndrome: a Clinical Perspective.调节激活的 PI3Kδ 综合征中的 PI3K 信号通路:临床视角。
J Clin Immunol. 2023 Dec 27;44(1):34. doi: 10.1007/s10875-023-01626-0.
2
The discovery of NLRP3 and its function in cryopyrin-associated periodic syndromes and innate immunity.NLRP3 的发现及其在 Cryopyrin 相关周期性综合征和先天免疫中的作用。
Immunol Rev. 2024 Mar;322(1):259-282. doi: 10.1111/imr.13292. Epub 2023 Dec 25.
3
Drug delivery systems for CRISPR-based genome editors.
用于基于CRISPR的基因组编辑工具的药物递送系统。
Nat Rev Drug Discov. 2023 Nov;22(11):875-894. doi: 10.1038/s41573-023-00762-x. Epub 2023 Sep 18.
4
Optimization of Cas9 activity through the addition of cytosine extensions to single-guide RNAs.通过向单导向 RNA 添加胞嘧啶延伸来优化 Cas9 活性。
Nat Biomed Eng. 2023 May;7(5):672-691. doi: 10.1038/s41551-023-01011-7. Epub 2023 Apr 10.
5
Activated PI3K delta syndrome 1 mutations cause neutrophilia in zebrafish larvae.激活的 PI3K delta 综合征 1 突变导致斑马鱼幼鱼嗜中性粒细胞增多。
Dis Model Mech. 2023 Mar 1;16(3). doi: 10.1242/dmm.049841. Epub 2023 Mar 13.
6
The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors.NLRP3 炎性小体激活的机制及其药理学抑制剂。
Front Immunol. 2023 Jan 18;13:1109938. doi: 10.3389/fimmu.2022.1109938. eCollection 2022.
7
Multiplex epigenome editing of to rescue Rett syndrome neurons.多重表观基因组编辑以挽救雷特综合征神经元。
Sci Transl Med. 2023 Jan 18;15(679):eadd4666. doi: 10.1126/scitranslmed.add4666.
8
CRISPR/Cas9 therapeutics: progress and prospects.CRISPR/Cas9 疗法:进展与展望。
Signal Transduct Target Ther. 2023 Jan 16;8(1):36. doi: 10.1038/s41392-023-01309-7.
9
Development of a novel knockout model of retinitis pigmentosa using -knockout Long-Evans rats.使用基因敲除的长 Evans 大鼠建立一种新型视网膜色素变性基因敲除模型。
Front Med (Lausanne). 2022 Sep 21;9:909182. doi: 10.3389/fmed.2022.909182. eCollection 2022.
10
CRISPR-Cas9-Mediated Gene Therapy in Neurological Disorders.CRISPR-Cas9 介导的神经疾病基因治疗。
Mol Neurobiol. 2022 Feb;59(2):968-982. doi: 10.1007/s12035-021-02638-w. Epub 2021 Nov 23.